Mitral Regurgitation Clinical Trial
Official title:
A Novel Adjustable Neochordae Technique in Mitral Valve Repair
Mitral valve (MV) repair has turned into a preferable option for surgeons over the MV
replacement. Since the 1960s, Surgeons use this technique for more efficiency and durability.
On the other hand, the proper determination of length and placement of artificial neochordae
is still a challenge beyond this technique. These challenges are still a vital area for
research and debate between surgeons and researchers.
In our novel technique,Investigators are not depending either on the preoperative
investigations or intraoperative reference chordae in the adjustment of the optimal length of
the neochordae, however, Researchers depend on the personal adjustment of the chordal length
to the prolapsed scallop.
Mitral regurgitation (prolapse) and mitral stenosis are examples of diseases that affect the
mitral valve. In mitral regurgitation, the leaflets do not close tightly and sway up and down
allowing the blood to flow backward from the left ventricle into the left atrium. on the
other hand, the mitral stenosis is caused by folding of thick leaflets of the valve which
fuses together leading to low blood flow from the left atrium into the left ventricle and
these cases are excluded from our trial. In mitral regurgitation, Surgeons prefer the mitral
valve repair over the mitral valve replacement, But still, there are a lot of challenges
towards this technique.
For decades, Surgeons used a lot of techniques to determine the length of neochordae includes
that:
Determination of neochordal length by transoesophageal echocardiography or by using a
landmark as a direct measurement. Previously, the surgeon applying the fixed loop length
technique by using a custom-made caliper, and on the distance between the edge of a
non-prolapsing segment and the tip of the papillary muscle (usually P1) to define the correct
loop length. There are different types of papillary muscle and chordae as regards the shape,
morphology, and length. So this reference distance is not fixed.
Adjusting neochordal length according to valve function. Length is chosen when the
regurgitation is completely removed. Existing of a large number of neochordae will make this
process more complex for the surgeon to decide.
Mitral valve (MV) repair has turned into a preferable option for surgeons over the MV
replacement. Since the 1960s, Surgeons use this technique for more efficiency and durability.
On the other hand, the proper determination of length and placement of artificial neochordae
is still a challenge beyond this technique. These challenges are still a vital area for
research and debate between surgeons and researchers.
In our novel technique, Investigators are not depending either on the preoperative
investigations or intraoperative reference chordae in the adjustment of the optimal length of
the neochordae, however, Researchers depend on the personal adjustment of the chordal length
to the prolapsed scallop.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03278574 -
Flexible Band vs Rigid Ring for Degenerative Mitral Valve Disease
|
N/A | |
Suspended |
NCT04960280 -
A Study to Evaluate a Computerized Stethoscope Called ©Voqx to Diagnose Heart Disease
|
N/A | |
Recruiting |
NCT05021614 -
Valveclip® Transcatheter Mitral Valve Repair Study
|
N/A | |
Not yet recruiting |
NCT06465745 -
AltaValve Pivotal Trial
|
N/A | |
Not yet recruiting |
NCT06167213 -
ALLIANCE Mitral: Safety and Effectiveness of SAPIEN X4 Transcatheter Heart Valve - Mitral
|
N/A | |
Withdrawn |
NCT05040451 -
Carillon Mitral Contour System for Treatment of Exercise Induced Functional Mitral Regurgitation
|
||
Withdrawn |
NCT03714412 -
Feasibility Study of Patients With Severe MR Treated With the Cardiovalve TMVR System
|
N/A | |
Recruiting |
NCT02592889 -
(MitraClip in Non-Responders to Cardiac Resynchronization Therapy)
|
Phase 4 | |
Completed |
NCT02355418 -
The Role of Myocardial Fibrosis in Degenerative Mitral Regurgitation
|
||
Completed |
NCT01841554 -
Cardioband With Transfemoral Delivery System
|
N/A | |
Not yet recruiting |
NCT01431222 -
Abrogation of Mitral Regurgitation Using the MitraClip System in High-Risk Patients Unsuitable for Surgery
|
Phase 4 | |
Not yet recruiting |
NCT03870516 -
Left Chamber Function in Mitral Regurgitation and Predicting Outcome After Replacement and Targeting for Early Surgery
|
N/A | |
Active, not recruiting |
NCT03230747 -
SAPIEN M3 EFS: Early Feasibility Study of the Edwards SAPIEN M3 System for the Treatment of Mitral Regurgitation
|
N/A | |
Enrolling by invitation |
NCT04031274 -
Transcatheter Treatment for Combined Aortic and Mitral Valve Disease. The Aortic+Mitral TRAnsCatheter (AMTRAC) Valve Registry
|
||
Completed |
NCT05836480 -
Immediate Suboptimal Result of Mitral Valve Repair: Late Implications in a Matched Cohort Study
|
||
Completed |
NCT05850026 -
Mitral Regurgitation in Hypertrophic Obstructive Cardiomyopathy: Fix it in a Simple, Effective and Durable Way!
|
||
Completed |
NCT05836532 -
Long Term Results of Surgical and Percutaneous Double Orefices Mitral Repair in Patient With p2 Prolapse Causing Degenerative Mitral Regurgitation
|
||
Recruiting |
NCT03975998 -
Dutch-AMR: Early Mitral Valve Repair Versus Watchful Waiting in Asymptomatic Patients With Severe Mitral Regurgitation
|
||
Completed |
NCT01162083 -
Identifying an Ideal Cardiopulmonary Exercise Test Parameter
|
N/A | |
Suspended |
NCT00787293 -
Study of Safety and Efficacy of the Percutaneous Reduction of Mitral Valve Regurgitation in Heart Failure Patients
|
Phase 2 |